A protein that stops cells from dividing in response to damage or stress could be a new biomarker or therapeutic target for ...

Dementia biomarkers -- phosphorylated tau (P-tau181), neurofilament light (NfL), and glial fibrillary acidic protein (GFAP) - ...

Pacific Protein Sequencing Market: Focus on Application, End User, and Country - Analysis and Forecast, 2024-2033" report has been added to ResearchAndMarkets.com's offering.The Asia-Pacific protein ...

A new study presented at ESCMID Global 2025 highlights interleukin-6 (IL-6) as a fast, accurate biomarker for early sepsis ...

ARUP Laboratories now provides a blood test for phosphorylated tau 217 (pTau 217) to assist in identifying whether cognitive decline symptoms in patients ages 60 years and older are related to ...

A new way to deliver disease-fighting proteins throughout the brain may improve the treatment of Alzheimer's disease and ...

A new study reveals that cognitive changes tied to Alzheimer's risk factors begin far earlier in life than previously thought, some as early as age 24.

A new way to deliver disease-fighting proteins throughout the brain may improve the treatment of Alzheimer's disease and other neurological disorders, according to University of California, Irvine ...

A new way to deliver disease-fighting proteins throughout the brain may improve the treatment of Alzheimer's disease and other neurological disorders, according to scientists. By engineering human ...

A new way to deliver disease-fighting proteins throughout the brain may improve the treatment of Alzheimer's disease ...

Explore how risk factors for Alzheimer's can impact cognitive function as early as age 24, paving the way for prevention strategies.

HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:​HCM; HKEX:​13) today announces that it has completed enrollment of the registration phase of its Phase II trial of savolitinib in gastric cancer ...